Bayesian methods have emerged as the driving force for methodological development in drug development. This edited book provides broad coverage of Bayesian methods in pharmaceutical research. The book includes contributions from some of the leading researchers in the field, and has been edited to ensure consistency in level and style.
Bayesian methods have emerged as the driving force for methodological development in drug development. This edited book provides broad coverage of Bayesian methods in pharmaceutical research. The book includes contributions from some of the leading researchers in the field, and has been edited to ensure consistency in level and style.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
I Introductory part Chapter 1: Bayesian Background Chapter 2: FDA Regulatory Acceptance of Bayesian Statistics Chapter 3: Bayesian Tail Probabilities for Decision Making II Clinical development Chapter 4: Clinical Development in the Light of Bayesian Statistics Chapter 5: Prior Elicitation Chapter 6: Use of Historical Data Chapter 7: Dose Ranging Studies and Dose Determination Chapter 8: Bayesian Adaptive Designs in Drug Development Chapter 9: Bayesian Methods for Longitudinal Data with Missingness Chapter 10: Survival Analysis and Censored Data Chapter 11: Benefit of Bayesian Clustering of Longitudinal Data: Study of Cognitive Decline for Precision Medicine Chapter 12: Bayesian Frameworks for Rare Disease Clinical Development Programs Chapter 13: Bayesian Hierarchical Models for Data Extrapolation and Analysis in Pediatric Disease Clinical Trials III Post-marketing Chapter 14: Bayesian Methods for Meta-Analysis Chapter 15: Economic Evaluation and Cost-Effectiveness of Health Care Interventions Chapter 16: Bayesian Modeling for Economic Evaluation Using "Real World Evidence" Chapter 17: Bayesian Benefit-Risk Evaluation in Pharmaceutical Research IV Product development and manufacturing Chapter 18: Product Development and Manufacturing Chapter 19: Process Development and Validation Chapter 20: Analytical Method and Assay Chapter 21: Bayesian Methods for the Design and Analysis of Stability Studies Chapter 22: Content Uniformity Testing Chapter 23: Bayesian methods for in vitro dissolution drug testing and similarity comparisons Chapter 24: Bayesian Statistics for Manufacturing V Additional topics Chapter 25: Bayesian Statistical Methodology in the Medical Device Industry Chapter 26: Program and Portfolio Decision-Making
I Introductory part Chapter 1: Bayesian Background Chapter 2: FDA Regulatory Acceptance of Bayesian Statistics Chapter 3: Bayesian Tail Probabilities for Decision Making II Clinical development Chapter 4: Clinical Development in the Light of Bayesian Statistics Chapter 5: Prior Elicitation Chapter 6: Use of Historical Data Chapter 7: Dose Ranging Studies and Dose Determination Chapter 8: Bayesian Adaptive Designs in Drug Development Chapter 9: Bayesian Methods for Longitudinal Data with Missingness Chapter 10: Survival Analysis and Censored Data Chapter 11: Benefit of Bayesian Clustering of Longitudinal Data: Study of Cognitive Decline for Precision Medicine Chapter 12: Bayesian Frameworks for Rare Disease Clinical Development Programs Chapter 13: Bayesian Hierarchical Models for Data Extrapolation and Analysis in Pediatric Disease Clinical Trials III Post-marketing Chapter 14: Bayesian Methods for Meta-Analysis Chapter 15: Economic Evaluation and Cost-Effectiveness of Health Care Interventions Chapter 16: Bayesian Modeling for Economic Evaluation Using "Real World Evidence" Chapter 17: Bayesian Benefit-Risk Evaluation in Pharmaceutical Research IV Product development and manufacturing Chapter 18: Product Development and Manufacturing Chapter 19: Process Development and Validation Chapter 20: Analytical Method and Assay Chapter 21: Bayesian Methods for the Design and Analysis of Stability Studies Chapter 22: Content Uniformity Testing Chapter 23: Bayesian methods for in vitro dissolution drug testing and similarity comparisons Chapter 24: Bayesian Statistics for Manufacturing V Additional topics Chapter 25: Bayesian Statistical Methodology in the Medical Device Industry Chapter 26: Program and Portfolio Decision-Making
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826